Galapagos receives transparency notification from FMR LLC
September 03 2024 - 4:01PM
Mechelen, Belgium; 3 September 2024, 22:01
CET; regulated information – Galapagos NV (Euronext & NASDAQ:
GLPG) received a transparency notification from FMR
LLC.
Pursuant to Belgian transparency legislation1,
Galapagos received a transparency notification on 30 August 2024
from FMR LLC, who notified that it holds 2,687,116 of Galapagos’
voting rights, consisting of 2,686,016 ordinary shares and 1,100
equivalent financial instruments. FMR LLC controls investment funds
Fidelity Management & Research Company LLC, FIAM LLC, Fidelity
Management Trust Company, Strategic Advisers LLC, and FMR
Investment Management (UK) Limited, of which Fidelity Management
& Research Company LLC decreased its position to 2,469,688
voting rights and 1,100 equivalent financial instruments (stock
loan), FIAM LLC decreased its position to 119,198 voting rights,
Fidelity Management Trust Company decreased its position to 11,879
voting rights, Strategic Advisers LLC maintained its position of 1
voting right, and FMR Investment Management (UK) Limited maintained
its position of 85,250 voting rights.
FMR LLC’s holding of 2,687,116 Galapagos’ voting
rights, including its controlled undertakings’ holdings, represents
4.08% of Galapagos’ currently outstanding 65,897,071 shares. FMR
LLC thus crossed below the 5% threshold of Galapagos’ voting
rights. The full transparency notice is available on the Galapagos
website.
About GalapagosWe are a
biotechnology company with operations in Europe and the U.S.
dedicated to developing transformational medicines for more years
of life and quality of life. Focusing on high unmet medical needs,
we synergize compelling science, technology, and collaborative
approaches to create a deep pipeline of best-in-class small
molecules and cell therapies in oncology and immunology. With
capabilities from lab to patient, including a decentralized cell
therapy manufacturing network, we are committed to challenging the
status quo and delivering results for our patients, employees, and
shareholders. For additional information, please
visit www.glpg.com or follow us
on LinkedIn or X.
For further information, please
contact:
Media
inquiries:Marieke Vermeersch +32 479 490
603 media@glpg.com Jennifer Wilson +44 7444
896759media@glpg.com |
Investor
inquiries:Sofie Van Gijsel +1 781 296
1143ir@glpg.comSandra Cauwenberghs +32 495 584
663ir@glpg.com |
1 Belgian Act of 2 May 2007 on the disclosure of
major shareholdings in issuers whose shares are admitted to trading
on a regulated market.
- GLPG EN PR_FMR LLC 30 August 2024_ENG
Galapagos (EU:GLPG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Galapagos (EU:GLPG)
Historical Stock Chart
From Sep 2023 to Sep 2024